Radiation OncologyRadiation InjuriesRadiotherapy DosageRadiotherapy, ConformalDose FractionationRadiotherapyCombined Modality TherapyMedical IllustrationBrachytherapyCyclic AMP-Dependent Protein Kinase Type IMedical OncologyRadiotherapy, Intensity-ModulatedRadiotherapy, AdjuvantChemoradiotherapyDose-Response Relationship, RadiationKarnofsky Performance StatusProstatic NeoplasmsTreatment OutcomeRadiotherapy Planning, Computer-AssistedSupratentorial NeoplasmsSurvival AnalysisAndrogen AntagonistsHead and Neck NeoplasmsOrgans at RiskRadiotherapy, High-EnergyBrain NeoplasmsCranial IrradiationHealth PhysicsRadiosurgeryAntineoplastic Combined Chemotherapy ProtocolsGoserelinNeoplasm StagingDisease-Free SurvivalCisplatinRadiation DosagePrognosisAmifostineLymphatic IrradiationSurvival RateRadiation, IonizingNeoplasm MetastasisChemotherapy, AdjuvantNeoplasm Recurrence, LocalClinical Trials, Phase III as TopicCarcinoma, Squamous CellLung NeoplasmsPelvisRectumNeoplasmsOncology NursingRadiotherapy, Computer-AssistedFollow-Up StudiesFlutamideRadiation ToleranceAnus NeoplasmsFluorouracilProportional Hazards ModelsRetrospective StudiesAdenocarcinomaTumor BurdenCancer Care FacilitiesRadiobiologyClinical Trials as TopicGlioblastomaKaplan-Meier EstimateDrug Administration ScheduleCarcinoma, Non-Small-Cell LungLymphatic MetastasisRadiotherapy, Image-GuidedProstate-Specific AntigenTomography, X-Ray ComputedPaclitaxelRadiationSocieties, MedicalMaximum Tolerated DoseTime FactorsRandomized Controlled Trials as TopicNeoadjuvant TherapyRadiation ProtectionAntineoplastic Agents, HormonalFeasibility StudiesTumor Markers, BiologicalRadiation MonitoringOncology Service, HospitalBreast NeoplasmsMultivariate AnalysisProspective StudiesRadiation PneumonitisQuality of LifeAntineoplastic AgentsRadiometryRadiology Department, HospitalNeoplasms, Radiation-InducedRadiation-Sensitizing AgentsRadiation Injuries, ExperimentalPositron-Emission TomographyVincristineQuality Assurance, Health CareGamma RaysCosmic Radiation